Bernardo B.
- Country
- Italy
- Department
- Prevenzione e Genetica Oncologica
Research Overview
- Evaluation of Time-Restricted Eating and Metformin Hydrochloride in Luminal Invasive Breast Cancer and Ductal Carcinoma In Situ: A Phase IIb Randomized Trial
- Phase II Biomarker Trial of Low-Dose Tamoxifen and Lifestyle Interventions for Breast Cancer Prevention in High-Risk Women
- Phase 2 Randomized Double-Blind Trial of Low-Dose Exemestane Versus Low-Dose Tamoxifen in Postmenopausal Women at High Risk for Breast Cancer
Data & Insights
Has run more than one trial at 2 of 6 partner sites.
Specializations
Breast Cancer Prevention
This investigator specializes in preventive approaches for women at increased breast cancer risk, particularly focusing on interventions using low dose tamoxifen combined with dietary modifications.
- High-Risk Population Management
- Preventive Endocrine Therapy
- Lifestyle Interventions
Their work encompasses the study of hormone-related biomarkers and their response to preventive interventions.
Therapeutic Innovation
The investigator explores novel therapeutic combinations including time-restricted eating and metformin treatment in breast cancer patients, with particular attention to presurgical interventions.
- Metabolic Interventions
- Fasting Protocols
- Drug Safety Assessment
Their research includes evaluation of tissue biomarkers in both invasive breast cancer and ductal carcinoma in situ.
Clinical Pathology
The investigator focuses on various forms of breast neoplasia, including intraepithelial neoplasia and hormone receptor-positive breast cancer.
- Molecular Pathology
- Biomarker Analysis
- Treatment Response Assessment
Their expertise extends to evaluating genetic risk factors and hereditary cancer syndromes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.